Biotech · Private company · Palo Alto, CA, US
Exai Bio Inc.
Track this companyFree. Adds Exai Bio Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- Exai oncRNA blood testCancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Prospective Study of oncRNA Stratification of Cancer by Size and StageRECRUITING · started Jul 14, 2023ClinicalTrials.gov NCT05833360 · fetched Nov 12, 2026
NIH awards2
- Orphan Non-coding RNA-based Test for Detecting Minimal Residual Disease in Resectable Non-small Cell Lung CancerFiscal year 2026 · $719KNIH RePORTER 5R44CA291369-02 · fetched Nov 12, 2026
- Orphan Non-coding RNA-based Test for Detecting Minimal Residual Disease in Resectable Non-small Cell Lung CancerFiscal year 2024 · $1.3MNIH RePORTER 1R44CA291369-01A1 · fetched Nov 12, 2026